首页> 外文OA文献 >The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome
【2h】

The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome

机译:通过系统性β-羟基丁酸酯的视网膜HCA2受体的激活通过减少内质网应激和NLRP3炎性抑制糖尿病视网膜损伤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

ObjectiveThe role of the hydroxycarboxylic acid receptor 2 (HCA2) in the retinal damage induced by diabetes has never been explored. In this context, the present study highlights an upregulation of retinal HCA2 receptors in diabetic C57BL6J mice. Moreover, we illustrate that HCA2 receptors exert an anti-inflammatory effect on the retinal damage induced by diabetes when activated by the endogenous ligand β-hydroxybutyrate.MethodologySeven-to-10-week-old C57BL6J mice were rendered diabetic by a single intraperitoneal injection of streptozotocin (75 mg/kg of body weight) and monitored intermittently over a 10-week period extending from the initial diabetes assessment. Mice with a fasting blood glucose level higher than 250 mg/dl for 2 consecutive weeks after streptozotocin injection were treated twice a week with intraperitoneal injections of 25-50-100 mg/kg β-hydroxybutyrate.ResultsInterestingly, while the retinal endoplasmic reticulum stress markers (pPERK, pIRE1, ATF-6α) were elevated in diabetic C57BL6J mice, their levels were significantly reduced by the systemic intraperitoneal treatment with 50 mg/kg and 100 mg/kg β-hydroxybutyrate. These mice also exhibited high NLRP3 inflammasome activity and proinflammatory cytokine levels. In fact, the elevated levels of retinal NLRP3 inflammasome activation markers (NLRP3, ASC, caspase-1) and of the relative proinflammatory cytokines (IL-1β, IL-18) were significantly reduced by 50 mg/kg and 100 mg/kg β-hydroxybutyrate treatment. These doses also reduced the high apoptotic cell number exhibited by the diabetic mice in the retinal outer nuclear layer (ONL) and increased the ONL low connexin 43 expression, leading to an improvement in retinal permeability and homeostasis.ConclusionsThese data suggest that the systemic treatment of diabetic C57BL6J mice with BHB activates retinal HCA2 and inhibits local damage.
机译:从未探索过羟基羧酸受体2(HCA2)在糖尿病诱导的视网膜损伤中的作用。在这种情况下,本研究强调了糖尿病C57BL6J小鼠中视网膜HCA2受体的上调。此外,我们说明HCA2受体在由内源性配体β-羟基丁酸酯激活时对糖尿病诱导的视网膜损伤产生抗炎作用。通过单一的腹膜内注射患糖尿病患者,患上的糖尿病β-羟基戊酸酯的C57BL6J小鼠的糖尿病患者链脲佐菌素(体重75毫克/千克),并在初始糖尿病评估延伸的10周内间歇监测。在链脲佐菌素注射液连续2周内连续250毫克/ dL高于250 mg / dl的小鼠每周用25-50-10-100mg / kgβ-羟基丁酸酯的腹膜注射治疗两次。结果,而视网膜内质子ressular标记物(PPERK,PITE1,ATF-6α)在糖尿病C57BL6J小鼠中升高,通过用50mg / kg和100mg / kgβ-羟基丁酸盐的全身腹腔处理显着降低了它们的水平。这些小鼠还表现出高NLRP3炎症组活动和促炎细胞因子水平。事实上,视网膜NLRP3炎症体活化标记物(NLRP3,ASC,Caspase-1)和相对促炎细胞因子(IL-1β,IL-18)的升高程度明显减少了50mg / kg和100mg / kgβ - 羟基丁酸盐处理。这些剂量还减少了视网膜外核层(ONL)中糖尿病小鼠表现出的高凋亡细胞数,并增加了ONL低conneclin 43表达,导致视网膜渗透性和稳态性的改善。结论的数据表明系统治疗具有BHB的糖尿病C57BL6J小鼠激活视网膜HCA2并抑制局部损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号